Lymphoma: all 5,624 studies
Page 47 of 57. Open to participants first (824), then studies with results posted, then the rest; newest registration first within each.
- Rituximab in Addition to Chemotherapy With Autologous Stem Cell Transplantation as Treatment Diffuse Large B-Cell LymphomaCompletedNCT00556127Phase 2
- Study of Pralatrexate in Patients With Relapsed or Refractory Cutaneous T-cell LymphomaCompletedNCT00554827Phase 1
- Positron Emission Tomography Guided Therapy of Aggressive Non-Hodgkin's LymphomasCompletedNCT00554164Phase 3
- Phase II Study to Evaluate the Combination of Rituximab and DepoCyte® in the C5R Chemotherapy Protocol in Patients Between the Ages of 18 and 60 Years With Primary Cerebral Non-Hodgkin Lymphoma and Systemic Diffuse Large B-cell Lymphoma With Neuromeningeal Invasion at DiagnosisCompletedNCT00553943Phase 2
- Safety Study of ABT-888 Plus Topotecan Hydrochloride to Treat Patients With Solid Tumors and LymphomasCompletedNCT00553189Phase 1
- Prediction of the Response to Chemotherapy by Tomoscintigraphie the MIBI in the Balance Sheet Pre Hodgkin's Disease and Lymphoma Malins High GradeCompletedNCT00551798Not applicable
- Fludarabine and Rituximab With or Without Pixantrone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin LymphomaWithdrawnNCT00551239Phase 3
- Multi-dose-escalation Safety and Pharmacokinetic Study of SAR3419 as Single Agent in Relapsed/Refractory B-cell Non Hodgkin's LymphomaCompletedNCT00549185Phase 1
- Ph I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLLCompletedNCT00546793Phase 1/2
- High-Dose Chemotherapy in Treating Patients Undergoing Stem Cell Transplant for Recurrent or Refractory Hodgkin's LymphomaCompletedNCT00544570Not applicable
- PET Scans in Patients With Diffuse Large B-Cell Lymphoma Receiving Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and PrednisoneCompletedNCT00544219Not applicable
- MGCD0103 Administered in Combination With Azacitidine (Vidaza®) to Subjects With Relapsed or Refractory Hodgkin or Non-Hodgkin LymphomaTerminatedNCT00543582Phase 2
- Combined CT Colonography and PET Imaging in Mantle Cell LymphomaWithdrawnNCT00541424
- Prospective Data Collection of Newly Diagnosed Hodgkin's Disease and Non-Hodgkin's Lymphoma CasesStatus unknownNCT00538551
- Obatoclax and Bortezomib in Treating Patients With Aggressive Relapsed or Recurrent Non-Hodgkin LymphomaTerminatedNCT00538187Phase 1
- A Phase I Study to Evaluate Safety, Tolerability in Adults With LymphomaWithdrawnNCT00538096Phase 1
- Study to Assess the Pharmacokinetics and Pharmacodynamics of GSK461364 in Subjects With Non-Hodgkins LymphomaCompletedNCT00536835Phase 1
- Treatment of Localized Low Grade LymphomasCompletedNCT00536458Phase 3
- Treatment of Disseminated High Grade LymphomaCompletedNCT00536393Phase 2/3
- Cytogenetic Analysis of Bone Marrow Specimen Prior to High Dose Chemotherapy and Autologous Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma or Hodgkin's DiseaseCompletedNCT00534820Not applicable
- Nonmyeloablative Allogeneic Stem Cell Transplantation From HLA-Matched Unrelated Donor for the Treatment of Hematologic DisordersCompletedNCT00533923Phase 2
- Safety of Soluble Beta-Glucan (SBG) in Treatment of Patients With Non-Hodgkin's LymphomaCompletedNCT00533728Phase 1
- FDG-PET-Stratified R-DICEP and R-Beam/ASCT For Diffuse Large B-Cell LymphomaCompletedNCT00530179Not applicable
- Idiotypic Vaccination for Follicular Lymphoma PatientsStatus unknownNCT00530140Phase 2
- A Randomized Phase IIb Placebo-Controlled Study of R-ICE Chemotherapy With and Without SGN-40 for Patients With DLBCLTerminatedNCT00529503Phase 2
- Phase I Trial of PX-478CompletedNCT00522652Phase 1
- Study Evaluating TRU-015 in B-Cell Non-Hodgkin's LymphomaTerminatedNCT00521638Phase 1
- A Study of Zevalin and Simultaneous Application of BEAM High-dose Chemotherapy Followed by Autologous Stem Cell Transplantation in Refractory and Relapsed Aggressive Non-Hodgkin LymphomasCompletedNCT00521560Phase 2
- Donor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other DiseaseCompletedNCT00521430Not applicable
- Donor T Cells, Low-Dose Aldesleukin, and Low-Dose GM-CSF After Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaWithdrawnNCT00521261Phase 1
- A Phase I, Study to Evaluate the Safety and Tolerability of Intravenous EZN-2208 in Patients With Advanced Solid Tumors or Lymphoma (EZN-2208-01)CompletedNCT00520637Phase 1
- A Phase I, Study to Evaluate the Safety and Tolerability of Intravenous EZN-2208 in Patients With Advanced Solid Tumors or Lymphoma (EZN-2208-02)CompletedNCT00520390Phase 1
- Dose-Dense Therapy in Aggressive LymphomaNo longer availableNCT00517894
- A Study of PRO95780 in Combination With Rituximab in Patients With Non-Hodgkin's Lymphoma That Has Progressed Following Previous Rituximab Therapy (APM4083g)CompletedNCT00517049Phase 2
- Everolimus in Treating Patients With Relapsed or Refractory Mantle Cell LymphomaCompletedNCT00516412Phase 2
- Safety Study of CAT-8015 Immunoxin in Patients With NHL With Advance DiseaseStatus unknownNCT00515892Phase 1
- HD18 for Advanced Stages in Hodgkins LymphomaCompletedNCT00515554Phase 3
- A Pilot Study of Standard-Dose Rituximab, Ifosfamide, Carboplatin and Etoposide (RICE) Plus Bortezomib (Velcade) in a Dose-Escalating Fashion for Patients With Relapsed or Primary Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma Who Are Candidates for Autologous Stem Cell TransplantTerminatedNCT00515138Early Phase 1
- Pilot Study of Umbilical Cord Blood Transplantation in Adult Patient With Advanced Hematopoietic MalignanciesTerminatedNCT00514722Not applicable
- Zevalin-BEAM/BEAC With Autologous Stem Cell Support as Consolidation in First Line Treatment of Mantle Cell LymphomaCompletedNCT00514475Phase 2
- Combination Chemotherapy With or Without Bortezomib in Treating Patients With Relapsed or Refractory Mantle Cell LymphomaCompletedNCT00513955Phase 2
- Combination Chemotherapy and Denileukin Diftitox in Treating Patients With Newly Diagnosed T-Cell Non-Hodgkin LymphomaWithdrawnNCT00513188Not applicable
- PVAG-14 Pilot for Intermediate Stages Hodgkin LymphomaTerminatedNCT00512980Phase 2
- Phase 1 Study of OPB-31121 in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma or Multiple MyelomaCompletedNCT00511082Phase 1
- PTK787 in Refractory or Relapsed Diffuse Large Cell LymphomaTerminatedNCT00511043Phase 2
- Personalized Active Immunotherapy (Vaccine Therapy) and Sargramostim Given After Standard of Care Treatment With Rituximab and Chemotherapy for Initial Treatment With LymphomaTerminatedNCT00510471Phase 2
- Abdominal Obesity and Cardiovascular Risk Factors in Women Who Survived Cancer or a Related Illness Following Total Body Irradiation and Stem Cell TransplantCompletedNCT00510315
- Non-randomized Safety Study With Bortezomib/Rituximab in Relapsed/Refractory Indolent LymphomaCompletedNCT00509379Phase 2
- Rituximab and Involved Field Radiotherapy in Early Stage Follicular LymphomaCompletedNCT00509184Phase 2
- Evaluation of a Novel CT-On-Rails or Trilogy Stereotactic Spine Radiotherapy System (SSRS)Active, not recruitingNCT00508443Phase 1/2
- Safety Study to Evaluate Induction and Consolidation Treatment in Patients With Mantle Cell Lymphoma (LCM-04-02)CompletedNCT00505232Phase 2
- MP470 in Treating Patients With Unresectable or Metastatic Solid Tumor or LymphomaTerminatedNCT00504205Not applicable
- Methotrexate and Temozolomide Versus Methotrexate, Procarbazine, Vincristine and CytarabineStatus unknownNCT00503594Phase 2
- A Study to Investigate the Effects of Ketoconazole on LBH589 in Patients With Advanced Solid TumorsCompletedNCT00503451Phase 1
- Forodesine in the Treatment of Cutaneous T-Cell LymphomaCompletedNCT00501735Phase 2
- Vorinostat in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma and Liver DysfunctionCompletedNCT00499811Phase 1
- Aprepitant or Ondansetron in Treating Nausea and Vomiting Caused By Opioids in Patients With CancerWithdrawnNCT00499668Not applicable
- A Trial of GS-9219 in Chronic Lymphocytic Leukemia (CLL), Non-Hodgkin's Lymphoma (NHL) or Multiple Myeloma (MM)TerminatedNCT00499239Phase 1/2
- Dose Dense Chemotherapy + Rituximab +/-Intensified High Dose Chemoimmunotherapy With Support of Peripheral Autologous Stem Cell in Diffuse Large B-Cell LymphomaStatus unknownNCT00499018Phase 3
- Study of YM155 in Refractory Diffuse Large B-cell Lymphoma (DLBCL) SubjectsTerminatedNCT00498914Phase 2
- The Prognostic Value of Interim PET/CT After 2 Cycles of Chemotherapy in Predicting Progression of Non Hodgkins LymphomaWithdrawnNCT00498667
- A Study of Two Associations of Rituximab and Chemotherapy, With a PET-driven Strategy, in LymphomaCompletedNCT00498043Phase 2
- phII Study of an HDAC Inhibitor in Very High-risk Relapsed/Refractory Hodgkin's Lymphoma PatientsTerminatedNCT00496431Phase 1/2
- Cisplatin With Gemcitabine With Dexamethasone in Patients With Aggressive Non-Hodgkin's LymphomaCompletedNCT00491127Phase 2
- Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic CancerCompletedNCT00489203Phase 2
- Molecular Epidemiology of Lymphoma PatientsWithdrawnNCT00488553
- Procurement of Follicular B Cell Lymphoma Cells for the Purpose of Possible Use in Future Clinical TrialsCompletedNCT00487513
- Study of the Safety and Pharmacokinetics of XL147 (SAR245408) in Adults With Solid Tumors or LymphomaCompletedNCT00486135Phase 1
- Epoetin Alfa or Epoetin Beta With or Without Iron Infusion in Treating Anemia in Patients With CancerStatus unknownNCT00482716Phase 3
- Phase II Study of Lenalidomide for the Treatment of Relapsed or Refractory Hodgkin's LymphomaCompletedNCT00478959Phase 2
- Phase I Trial of Clofarabine in Combo w/ HD Etoposide & Cyclophosphamide and APBSCT for Pts w/ High-Risk or Refractory NHLCompletedNCT00477945Phase 1
- A Randomized Phase II Study of Oral Sapacitabine in Patients With Advanced Cutaneous T-cell LymphomaTerminatedNCT00476554Phase 2
- Anti-Third Party T Lymphocytes With Nonmyeloablative Stem Cell Transplantation for Indolent Lymphoid MalignanciesTerminatedNCT00473551Phase 1
- Phase I, Open-label, Dose-escalation, Safety and PK Study of AZD4877TerminatedNCT00471367Phase 1
- Pemetrexed and Oxaliplatin in Treating Patients With Metastatic Solid Tumors or LymphomaCompletedNCT00470405Phase 1
- Phase 1 Study of EZN-2968 Weekly in Adult Patients With Advanced Solid Tumors or LymphomaCompletedNCT00466583Phase 1
- LINFOTARGAM: Treatment With Chemotherapy Plus Rituximab and Highly Active Antiretroviral Therapy in Patients With Diffuse Large B Cell Lymphoma and Infection With the Human Immunodeficiency Virus (HIV)CompletedNCT00466258Phase 4
- Zevalin and BEAM High-dose Chemotherapy Compared With BEAM Alone as Conditioning Regimen in Patients With Chemosensitive Relapse of Non-Hodgkin's LymphomaStatus unknownNCT00463463Phase 3
- Biaxin Based Antibiotic Therapy in Previously Untreated, Advanced Stage Indolent LymphomaCompletedNCT00461084
- Phase I, Open-label, Dose Escalation of AZD4877 in Hematologic MalignanciesTerminatedNCT00460460Phase 1
- Talotrexin in Treating Young Patients With Recurrent Solid Tumors or Leukemia That is Recurrent or Does Not Respond to TreatmentWithdrawnNCT00458744Phase 1
- Bevacizumab and Cediranib Maleate in Treating Patients With Metastatic or Unresectable Solid Tumor, Lymphoma, Intracranial Glioblastoma, Gliosarcoma or Anaplastic AstrocytomaCompletedNCT00458731Phase 1
- A Phase I Safety, PK and PD Study of KW-2478 in Patients With Multiple Myeloma, Chronic Lymphocytic Leukaemia or B-cell Non-Hodgkin's LymphomaCompletedNCT00457782Phase 1
- Safety and Efficacy of GMX1777 in the Treatment of Refractory Solid Tumors or LymphomasWithdrawnNCT00457574Phase 1
- CHOP-Rituximab Augmented With GM-CSF in Patients With Previously Untreated Diffuse Large B Cell Non-Hodgkin's LymphomaTerminatedNCT00455897Phase 2
- Dietary Intervention in Follicular LymphomaStatus unknownNCT00455416Phase 2
- a Phase II Study in Primary Central Nervous System LymphomaStatus unknownNCT00455286Phase 2
- Alemtuzumab and CHOP Chemotherapy for Aggressive Histological Peripheral T-Cell LymphomasCompletedNCT00453427Phase 1/2
- A Trial of the Safety of Escalating Doses of PRO131921 in Patients With Relapsed or Refractory Indolent Non-Hodgkin's LymphomaTerminatedNCT00452127Phase 1/2
- Safety of Batracylin in Patients With Solid Tumors and LymphomasCompletedNCT00450502Phase 1
- Early Hospital Discharge or Standard Inpatient Care in Cancer Patients Receiving Antibiotics for Febrile NeutropeniaStatus unknownNCT00445497Phase 3
- Aurora Kinase Inhibitor AT9283 in Treating Patients With Advanced or Metastatic Solid Tumors or Non-Hodgkin's LymphomaCompletedNCT00443976Phase 1
- Safety and Efficacy Study of TNX-650 to Treat Refractory Hodgkin's LymphomaStatus unknownNCT00441818Phase 1/2
- The Effectiveness of Alemtuzumab Combination With CHOP to Treat Patients Newly Diagnosed With PTCLTerminatedNCT00441025Phase 2
- An Observational Study of Lymphoma in Patients With Rheumatoid Arthritis or Crohn's Disease.CompletedNCT00440817
- The Response Study of Yt90-Zevalin in Patients With Diffuse Large B-cell Lymphoma After 6 Cycles of CHOPCompletedNCT00440583Phase 2
- Safety & Efficacy Study of AT-101 in Combination w/ Rituximab in Previously Untreated Grade I-II Follicular Non-Hodgkin's LymphomaCompletedNCT00440388Phase 2
- Velcade Plus ICE for Patients With Relapsed Classical Hodgkin LymphomaCompletedNCT00439361Phase 1
- Sibling Donor Peripheral Stem Cell Transplant or Sibling Donor Bone Marrow Transplant in Treating Patients With Hematologic Cancers or Other DiseasesCompletedNCT00438958Phase 3
- Study Combining Zevalin With High-Dose Chemotherapy Prior to Autologous StemCell Transplant in Patients With Relapsed, Refractory, or Transformed Non-Hodgkin's LymphomaStatus unknownNCT00438581Phase 2